A Comparative Study of Alanine Aminotransferase & Alkaline Phosphatase in Type-2 DiabeticPatients and Non-Diabetics

Study of Alanine Aminotransferase & Alkaline Phosphatase

Authors

  • Vishaldeep D. Gohel
  • Nimisha Gajera
  • Pankaj Panchal
  • Jasmin Parmar

DOI:

https://doi.org/10.70284/njirm.v5i5.803

Keywords:

DM (Diabetes Mellitus), ALT (Alanine aminotransferase), ALP (alkaline phosphatase)

Abstract

Background: The aim of this study was to find out the liver function test abnormalities in a group of diabetic type-2 patients in Jamnagar, Gujarat and to determine the factors associated with these biochemical changes. Method: In this cross sectional study conducted at the diabetic clinic in GGH General Hospital, Jamnagar between May 2012 and April 2013, a total of 100 patients were included. Parameters like serum alanine aminotransferase (ALT), alkaline phosphatase (ALP) used. Result: Raised ALT was noted in 30 % of diabetes type -2 patients while in control group 6% had elevated value. Elevations in serum alkaline phosphatase (ALP) were found in 38 %. Mean value of ALT & ALP had no correlation with gender of the diabetes patients. In conclusion, abnormal liver function results are more common among diabetes patients. Elevated ALT and ALP are the markers for associated non alcoholic fatty liver disease in diabetes patients. [Gohel V NJIRM 2014; 5(5):52-56]

References

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetes Med 1997; 14(5): 81–85.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5):1047–1053.
3. Chatila R, West AB. Hepatomegaly and abnormal liver tests due to glycogenosis inadults with diabetes. Medicine 1996; 75(6):327-33.
4. Levinthal G.N, Tavill A.S. Liver disease and diabetes mellitus. Clin Diabetes 1999; 17 (2): 1–20.
5. Kenneth Cusi. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Current Opinion in Endocrinology, Diabetes & Obesity 2009; 16:141–149.
6. Meybodi M A, Afkhami-Ardekani M, Rashidi M. Prevalence of Abnormal Serum Alanine Aminotransferase Levels in Type 2 Diabetic Patients in Iran. Pakistan Journal of Biological Sciences 2008; 11: 2274-2277.
7. ShobhaLuxmi, Rukhsana Abdul Sattar et al. Association of Non Alcoholic Fatty Liver with type 2 Diabetes Mellitus. JLUMHS 2008; 188-193.
8. Ayman S. Idris, Koua Faisal et al.Liver function tests in type 2 Sudanese diabetic patients, International Journal of Nutrition and Metabolism 2011; 3(2): 17-21.
9. M Prashanth, HK Ganesh, MV Vimal et al. Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus, JAPI 2009; 57: 205-210.
10. J WEST, Alan Wall, Parijat De. Prevalence of abnormal liver function tests in patients with diabetes mellitus Endocrine Abstracts 2007; 13:157-162.
11. Paruk IM, Pirie FJ, et al. High prevalence of abnormal liver enzymes in South African patients with type 2 diabetes mellitus attending a diabetes clinic, JEMDSA 2011; 16: 43-47.
12. Han Ni, HtooHtooKyawSoe,et al. Determinants of Abnormal Liver Function Tests in Diabetes Patients in Myanmar, International Journal of Diabetes Research 2012, 1(3): 36-41.

Downloads

Published

2018-01-05

How to Cite

Gohel, V. D., Gajera, N., Panchal, P., & Parmar, J. (2018). A Comparative Study of Alanine Aminotransferase & Alkaline Phosphatase in Type-2 DiabeticPatients and Non-Diabetics: Study of Alanine Aminotransferase & Alkaline Phosphatase. National Journal of Integrated Research in Medicine, 5(5), 53–57. https://doi.org/10.70284/njirm.v5i5.803

Issue

Section

Original Articles